Throughout the last three months, 13 analysts have evaluated Hims & Hers Health (NYSE:HIMS), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...

Bullish option flow detected in Hims and Hers Health with 16,443 calls trading, 1.2x expected, and implied vol increasing almost 7 points to 108.46%. May-25 35 calls and 4/25 weekly 30 calls are ...

Hims & Hers has shown explosive growth, with potential revenue of $2.5B in FY25, trading at a low 2.4x FY25 sales. Despite the high short interest and bear arguments, HIMS' data-driven ...

In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $28.10, with a -0.14% movement compared to the previous day. This change lagged the S&P 500's daily gain of 0.74%. Elsewhere ...

While there's still plenty of work to be done, Hims is one of many such companies that's helping to expand healthcare options, by opening the conversation around men's health, in particular.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company ...